In a study on hepatocellular carcinoma (HCC), IL-11 was shown to promote tumor cell proliferation and resistance to apoptosis by activating the STAT3 signaling pathway, contributing to cancer recurrence in postoperative HCC patients (33). Here, IL11 is linked to hepatocellular carcinoma.